von Maltzahn Geoffrey 4
4 · Sana Biotechnology, Inc. · Filed Feb 10, 2021
Insider Transaction Report
Form 4
von Maltzahn Geoffrey
Director
Transactions
- Conversion
Common Stock
2021-02-08+1,464,488→ 1,464,488 total - Conversion
Common Stock
2021-02-08+366,122→ 366,122 total(indirect: Held by the Geoffrey A. von Malzahn 2020 GRAT) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−366,122→ 0 total(indirect: Held by the Geoffrey A. von Malzahn 2020 GRAT)→ Common Stock (366,122 underlying) - Conversion
Series A-2 Convertible Preferred Stock
2021-02-08−1,464,488→ 0 total→ Common Stock (1,464,488 underlying)
Footnotes (2)
- [F1]The shares of Issuer's Preferred Stock automatically convert into shares of Issuer's Common Stock, for no additional consideration, on a 1-for-1 basis immediately prior to the consummation of Issuer's initial public offering.
- [F2]The expiration date is not relevant to the conversion of these securities.